These findings indicate that basal levels of TREM-1 are about two-fold lower in circulating monocytes from CF patients than in healthy individuals, and suggest a possible explanation for the observed inability of these cells to mount an inflammatory response. The gene discussed is TREM1; the disease is cystic fibrosis.